Closely relying on Peking University Health Science Center
In May 2013, Peking University Health Science Center and Founder Group signed the strategic cooperation agreement
Peking University Health Science Center owns a top-level medical-education-R&D system in China. It will help to build the medicine R&D platform, train R&D team, accelerate the industrialization of R&D achievements, improve the internationalization strategy and develop the medicine industry under the agreement betweenPKU Healthcare and Peking University Health Science Center.

R&D
●Rely on the profound academic foundation and resources of Peking University Health Science Center.
●Make good use of the arrangement of PKU Care Pharmaceutical R&D Center, R&D of PKU HealthCare Co., Ltd and R&D of Chongqing Daxin Pharmaceutical Co., Ltd.
●Realize the full coverage of R&D of innovative drugs and reform of technology.

Manufacturing 
●PKU HealthCare Co. Ltd and Daxin Pharmaceuticals are the key enterprises of Chinese pharmaceutical industry with more than 20 categories and 200 products after a splendid development history of decades.
●Own an internationally compatible biopharmaceutical and chemical pharmaceutical manufacturing base which meets cGMP standard and EHS.
●Own the medicine manufacturing equipments which are leading in Chinese industry and advanced in the international industry.
●We are an influential Lovastatin and Sulfonamides manufacturing enterprise all over the world.

Certifications 
●We are one of the top pharmaceutical enterprises owning the most certifications in China.
●All the products have been approved by GMP.
●Twelve products have successfully passed US FDA site inspections and seven products have been granted CEP till 2013.

Distribution
Global distribution
●Founder Pharma Co., Ltd.: import and export platform. 
●Hong Kong Founder Pharma: self-hold international business platform.
●PKU Pharmaceutical Chongqing Fongkong Co., Ltd.: the professional preparation marketing platform for formulations produced by PKU HealthCare Co., Ltd and Daxin Pharmaceutical. 
●Beijing Beiyi Pharmaceutical Co., Ltd: the largest logistics platform in northern China, agent of several high-end products cooperated with international famous enterprises like Abbott and Devin. 
●PKU Pharmaceutical Wuhan Yekaitai Co., Ltd.: the largest logistics platform in central China,

Policy
The Twelfth Five-year Plan of national medicine and Revitalization Plan for Chongqing medicine industry 
●China will become the second largest medicine market according to the Twelfth Five-year Plan.
●It is clearly pointed out that the government will foster medicine industry with the focus on supporting for the leading enterprises like PKU Health Care and Daxin Pharmaceuticals and make the big three: PKU Health Care, Taiji Group and Chongqing Chemical and Pharmaceutical Holding (Group) Corporation bigger and stronger in Some Suggestions About to Improve New Industrialization, Notice of Three-year Revitalization Plan for Chongqing Consumer Goods Industry and workshops of revitalization plan for Chongqing medicine industry established by Chongqing government in Aug, 2008.